Primmune Therapeutics Awarded DTRA Funding for Lassa Fever Antiviral Medical Countermeasures March 20, 2024 …
U.S. Army Laboratory Technicians Train with Romanian Troops at Bucharest Biological Research Facility CBRNE September 1, 2023 …
VitriVax Wins DoD Contract to Develop Single-Shot Vaccine for Melioidosis and Glanders Industry News July 19, 2023 …
Capacity Building: Plans for a Public Health Emergency Operations Center in Armenia Contracts + Grants July 5, 2023 …
Los Alamos Researchers to Help Revolutionize Future of Vaccine Development Medical Countermeasures November 3, 2022 …
Looking Back at the Biological Threat Reduction Program Through the Decades Biosecurity October 17, 2021 …
“Resurrector” Drugs Have Potential to Rescue Aged AChE to Fight Nerve Agents CBRNE October 17, 2021 …
MIT Researchers Make Progress on Antibiotic Resistance Under DTRA-JSTO Research Program Antimicrobial Resistance October 12, 2021 …
First-in-Class Nerve Agent Antidote Crosses Blood-Brain Barrier to Aid Central Nervous System CBRNE October 12, 2021 …
Dial-a-Threat Rapid Assay Generation Program Could Bypass Reliance on Cold-Chain Supply Biodetection October 8, 2021 …
DTRA Works to Create Freeze-Dried Portable Biomanufacturing for Nimble Response to Emerging Biothreats Medical Countermeasures September 30, 2021 …
Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development Antimicrobial Resistance January 26, 2021 …
Originally Built for Bioterrorism Agents, This Decontamination System Now Clears SARS-CoV-2 from Military Aircraft CBRNE November 5, 2020 …
